Animal models in food allergy: assessment of allergenicity and preventive activity of infant formulas.
Food allergies occur in about 5-10% of the overall infant and small-child population. Cow's milk protein allergy (CMPA) is the most common in young infants, with a 2-4% incidence. When breastfeeding is not possible, hypoallergenic (HA) cow's milk based formulas are usually given during the first months of life for prevention of CMPA. Depending on primary (sensitization) or secondary (triggering) prevention, the requested quality of HA formulas may be different. Besides in vitro methods, in vivo and ex vivo animal models are helpful in assessing residual allergenicity and the preventive effect of HA formulas. The sensitizing capacity of a formula can be examined by either the parenteral rat (IgE), the guinea pig (IgG1a mediated) or the oral mouse (IgE) models. The triggering IgE mediated allergenicity is tested by a parenteral rat model with oral gavage for intestinal mast cell protease (RMCPII) release. These animal models are also used for testing the oral tolerance inducing capacities of formulas. Together with cellular in vitro assays, animal models are very helpful in predicting allergenicity and the tolerogenic potential of HA infant formulas.
Fritsché
Rodolphe
R
Nestlé Research Center, Vers-chez-les-Blanc, P.O. Box 44, CH-1000 26, Lausanne, Switzerland. rodolphe.fritische@rdls.nestle.com
D000818:Animals; D053818:Chymases; D005512:Food Hypersensitivity / Q000175:diagnosis / Q000378:metabolism / Q000517:prevention & control; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000453:epidemiology / Q000209:etiology* / Q000517:prevention & control; D007223:Infant; D007225:Infant Food / Q000009:adverse effects*; D023421:Models, Animal; D012697:Serine Endopeptidases / Q000378:metabolism*
D012697:Serine Endopeptidases; D053818:Chymases